New Key Statistics Module, Z-Score and F-Score
SZSE:002038 Key Ratios
Market Cap ¥ M | 6,985.98 |
Enterprise Value ¥ M | 5,840.55 |
P/E(ttm) | 24.29 |
PE Ratio without NRI | 25.00 |
Forward PE Ratio | -- |
Price/Book | 1.19 |
Price/Sales | 7.13 |
Price/Free Cash Flow | 28.10 |
Price/Owner Earnings | 111.44 |
Payout Ratio % | 0.37 |
Revenue (TTM) ¥ M | 966.00 |
EPS (TTM) ¥ | 0.28 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | -3.30 |
5-y EBITDA Growth Rate % | -11.60 |
y-y EBITDA Growth Rate % | 53.40 |
EV-to-EBIT | 12.86 |
EV-to-EBITDA | 12.86 |
PEG | -- |
Shares Outstanding M | 1,027.35 |
Net Margin (%) | 29.47 |
Operating Margin % | 24.75 |
Pre-tax Margin (%) | 31.57 |
Quick Ratio | 7.18 |
Current Ratio | 7.67 |
ROA % (ttm) | 4.62 |
ROE % (ttm) | 4.96 |
ROIC % (ttm) | 4.56 |
Dividend Yield % | 2.20 |
Altman Z-Score | 11.56 |
SZSE:002038 Number of Guru Trades
SZSE:002038 Volume of Guru Trades
Gurus Latest Trades with SZSE:002038
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002038 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beijing SL Pharmaceutical Co Ltd Insider Transactions
No Available Data